The deal includes $250 million in cash upfront and additional payments based on reaching commercial and reimbursement milestones.
Medtechdive
Share
The company plans to use most of the $3.7 billion in after-tax proceeds from the biopharma solutions sale to repay debt.
Medtechdive
Share
The company paid $300 million to buy certain maternal fetal medicine and gynecological surgery products.
Medtechdive
Share
Companies can make limited modifications on certain devices and manufacturing processes to address supply shortages or production limitations.
Medtechdive
Share
Investor concerns that interest in GLP-1s will slow demand for medical devices and procedures have shaved roughly $370 billion in value from stocks across the medtech sector, according to research by Mizuho.
Medtechdive
Share
President Joe Biden outlined the planned program as part of an executive order on “safe, secure, and trustworthy” AI.
Medtechdive
Share